Krystal Biotech, Inc. has initiated its Phase 3 clinical trial, named IOLITE, to evaluate KB803, a gene therapy designed to treat and prevent corneal abrasions in patients with dystrophic ...

Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing by 3 months as well as significant visual acuity improvement from hand ...

NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vaccines based on its T-win ® platform, ...

While digital technologies have reshaped many industries, healthcare is one of the last to rely on faxes and phone calls. This holds true for workflows in physician offices and hospitals, which are ...

While much attention has been given to the novel science behind cell and gene therapies (CGTs), the success of every precision medicine starts and ends with the patient. The novel science behind CGTs ...

After starting his career as a pharmacist, Brian Laird decided to focus on the business-side of healthcare. He recently joined EVERSANA as its president of Patient Services, where uses his experience ...